211 related articles for article (PubMed ID: 37376203)
1. Protein Corona Attenuates the Targeting of Antitumor Sialyl Lewis X-Decorated Liposomes to Vascular Endothelial Cells under Flow Conditions.
Onishchenko NR; Moskovtsev AA; Kobanenko MK; Tretiakova DS; Alekseeva AS; Kolesov DV; Mikryukova AA; Boldyrev IA; Kapkaeva MR; Shcheglovitova ON; Bovin NV; Kubatiev AA; Tikhonova OV; Vodovozova EL
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376203
[TBL] [Abstract][Full Text] [Related]
2. Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.
Kuznetsova NR; Stepanova EV; Peretolchina NM; Khochenkov DA; Boldyrev IA; Bovin NV; Vodovozova EL
J Drug Target; 2014 Oct; 22(3):242-250. PubMed ID: 24313904
[TBL] [Abstract][Full Text] [Related]
3. Interactions of antitumour Sialyl Lewis X liposomes with vascular endothelial cells.
Alekseeva A; Kapkaeva M; Shcheglovitova O; Boldyrev I; Pazynina G; Bovin N; Vodovozova E
Biochim Biophys Acta; 2015 May; 1848(5):1099-110. PubMed ID: 25646577
[TBL] [Abstract][Full Text] [Related]
4. [Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer].
Mouseeva EV; Kuznetsova NR; Svirshchevskaia EV; Bovin NV; Sitnikov NC; Shavyrin AS; Beletskaia IP; Combes S; Fedorov AIu; Vodovozova EL
Biomed Khim; 2012; 58(3):326-38. PubMed ID: 22856138
[TBL] [Abstract][Full Text] [Related]
5. Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.
Kuznetsova NR; Sevrin C; Lespineux D; Bovin NV; Vodovozova EL; Mészáros T; Szebeni J; Grandfils C
J Control Release; 2012 Jun; 160(2):394-400. PubMed ID: 22210161
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug.
Tretiakova D; Le-Deigen I; Onishchenko N; Kuntsche J; Kudryashova E; Vodovozova E
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33915726
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Functional Characterization of Novel Sialyl LewisX Mimic-Decorated Liposomes for E-selectin-Mediated Targeting to Inflamed Endothelial Cells.
Chantarasrivong C; Ueki A; Ohyama R; Unga J; Nakamura S; Nakanishi I; Higuchi Y; Kawakami S; Ando H; Imamura A; Ishida H; Yamashita F; Kiso M; Hashida M
Mol Pharm; 2017 May; 14(5):1528-1537. PubMed ID: 28191842
[TBL] [Abstract][Full Text] [Related]
8. Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model.
Vodovozova EL; Moiseeva EV; Grechko GK; Gayenko GP; Nifant'ev NE; Bovin NV; Molotkovsky JG
Eur J Cancer; 2000 May; 36(7):942-9. PubMed ID: 10785601
[TBL] [Abstract][Full Text] [Related]
9. Influence of stabilizing components on the integrity of antitumor liposomes loaded with lipophilic prodrug in the bilayer.
Tretiakova D; Onishchenko N; Boldyrev I; Mikhalyov I; Tuzikov A; Bovin N; Evtushenko E; Vodovozova E
Colloids Surf B Biointerfaces; 2018 Jun; 166():45-53. PubMed ID: 29533843
[TBL] [Abstract][Full Text] [Related]
10. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
[TBL] [Abstract][Full Text] [Related]
12. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.
Zeisig R; Stahn R; Wenzel K; Behrens D; Fichtner I
Biochim Biophys Acta; 2004 Jan; 1660(1-2):31-40. PubMed ID: 14757218
[TBL] [Abstract][Full Text] [Related]
13. Disposition of E-selectin-targeting liposomes in tumor spheroids with a perfusable vascular network.
Chantarasrivong C; Okada R; Yamane Y; Yang X; Higuchi Y; Konishi M; Komura N; Ando H; Yokokawa R; Yamashita F
Drug Metab Pharmacokinet; 2022 Dec; 47():100469. PubMed ID: 36174354
[TBL] [Abstract][Full Text] [Related]
14. Liposomal Formulation of a Melphalan Lipophilic Prodrug: Studies of Acute Toxicity, Tolerability, and Antitumor Efficacy.
Tretiakova D; Svirshchevskaya E; Onishchenko N; Alekseeva A; Boldyrev I; Kamyshinsky R; Natykan A; Lokhmotov A; Arantseva D; Shobolov D; Vodovozova E
Curr Drug Deliv; 2020; 17(4):312-323. PubMed ID: 32056524
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of L-selectin binding by polyacrylamide-based conjugates under defined flow conditions.
Enders S; Bernhard G; Zakrzewicz A; Tauber R
Biochim Biophys Acta; 2007 Oct; 1770(10):1441-9. PubMed ID: 17707590
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer.
Kuznetsova NR; Vodovozova EL
Biochemistry (Mosc); 2014 Aug; 79(8):797-804. PubMed ID: 25365489
[TBL] [Abstract][Full Text] [Related]
17. Transvascular accumulation of Sialyl Lewis X conjugated liposome in inflamed joints of collagen antibody-induced arthritic (CAIA) mice.
Minaguchi J; Oohashi T; Inagawa K; Ohtsuka A; Ninomiya Y
Arch Histol Cytol; 2008 Nov; 71(3):195-203. PubMed ID: 19194042
[TBL] [Abstract][Full Text] [Related]
18. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links.
Wenzel CT; Scher RL; Richtsmeier WJ
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1279-86. PubMed ID: 7576475
[TBL] [Abstract][Full Text] [Related]
19. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
20. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
